Found 2,514 results
By David Dittman On January 4, 202104:30 PM Eastern
Bitcoin and the No. 2 cryptocurrency, Ethereum, are staging rallies that have attracted all sorts of eyeballs, including some of the biggest investors in the world, as well as regular folks just...
By Jessica Borg On June 20, 202106:00 AM Eastern
There’s no avoiding a certain word these days when it comes to stock market analysis: inflation.
“If you keep pumping money into the economy, eventually you’re going to see inflation ... Now we...
By Gavin Magor On February 18, 202507:00 AM Eastern
Here’s a simple Weiss Ratings screen to keep your portfolio clear of crashing stocks.
By Mike Larson On May 22, 201908:00 AM Eastern
What goes up must come down. I’m sure you’ve heard that expression a million times before.
But for today’s stock market, a better version might be: “What takes off like a Polaris missile ......
By Kelly Green On May 5, 202207:00 AM Eastern
Recently, I’ve been spending most of my free time reading earnings announcements. And I immediately started wondering about semiconductors.
By Jon D. Markman On December 8, 202207:00 AM Eastern
Deglobalization and energy transition will be a boon for the chip sector. Here’s how you can profit from this megatrend.
By Mandeep Rai On December 6, 201708:09 AM Eastern
Too many investors beg and plead for a chance to get on board with winning stocks. Then when those stocks do take a breather, they get cold feet! Of course, soon afterwards, the stocks in question...
By Mandeep Rai On March 29, 201707:00 AM Eastern
Sentiment readings have been soaring post-election, with the possibility of tax cuts, regulation reforms, and infrastructure programs clearly getting people excited.
In fact, yesterday’s...
By Mike Larson On June 5, 201908:00 AM Eastern
Forgive me for being blunt. But there is a TON of “Fed Fiction” floating around out there right now.
Frankly, that worries me sick ... because listening to it could cost YOU money! So, I’m going...
By The Weiss Ratings Team On March 21, 201607:00 AM Eastern
On Tuesday, March 15th, a massive 51 percent decline in Valeant Pharmaceuticals International, Inc. (VRX) wreaked havoc in the stock market and caused hefty losses to many. VRX started the day...